Ralf Lutterbüse
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 5%
- CAR-T cell therapy research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 10
-
- Glycosylation and Glycoproteins Research 5
- Protein purification and stability 1
- Co-authors
- Peter Kufer (12 shared papers)Patrick A. Baeuerle (7 shared papers)Gert Riethmüller (5 shared papers)Ralf C. Bargou (3 shared papers)Florian Zettl (3 shared papers)Anja Löffler (1 shared paper)Jan M. Schwenkenbecher (1 shared paper)Peter T. Daniel (1 shared paper)
- Journals
- Blood (2 papers)Cancer Immunology Immunotherapy (2 papers)The Journal of Immunology (1 paper)Immunobiology (1 paper)Trends in biotechnology (1 paper)
- Partner nations
- Germany
In The Last Decade
Ralf Lutterbüse
13 papers receiving 970 citations
Peers
Comparison fields: 5 of 52
- Radiology, Nuclear Medicine and Imaging 566
- Oncology 613
- Immunology 405
- Pathology and Forensic Medicine 87
- Genetics 52
Countries citing papers authored by Ralf Lutterbüse
This map shows the geographic impact of Ralf Lutterbüse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Lutterbüse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Lutterbüse more than expected).
Fields of papers citing papers by Ralf Lutterbüse
This network shows the impact of papers produced by Ralf Lutterbüse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Lutterbüse. The network helps show where Ralf Lutterbüse may publish in the future.
Co-authors
The 25 scholars most cited alongside Ralf Lutterbüse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 359 | |
| 2 | 2003 | 156 | |
| 3 | 2009 | 145 | |
| 4 | 2004 | 114 | |
| 5 | Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease. | 2002 | 64 |
| 6 | 2005 | 45 | |
| 7 | Bispecific antibodies for polyclonal T-cell engagement. | 2003 | 42 |
| 8 | 1997 | 38 | |
| 9 | Minimal costimulatory requirements for T cell priming and TH1 differentiation: activation of naive human T lymphocytes by tumor cells armed with bifunctional antibody constructs. | 2001 | 28 |
| 10 | Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells. | 2000 | 26 |
| 11 | 2005 | 15 | |
| 12 | 2006 | 4 | |
| 13 | The promise of bispecific antibodies. | 2004 | 2 |
About Ralf Lutterbüse
Ralf Lutterbüse is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology, Oncology and Genetics, having authored 13 papers that have together received 1.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (5 papers), CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (4 papers), Toxin Mechanisms and Immunotoxins (2 papers), T-cell and B-cell Immunology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Protein purification and stability (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (566 citations), Oncology (613 citations), Immunology (405 citations), Pathology and Forensic Medicine (87 citations) and Genetics (52 citations). Ralf Lutterbüse has collaborated with scholars based in Germany. Frequent co-authors include Peter Kufer, Patrick A. Baeuerle, Gert Riethmüller, Ralf C. Bargou, Florian Zettl, Anja Löffler, Jan M. Schwenkenbecher, Peter T. Daniel, Bernd Schlereth and Klaus Brischwein. Their work appears in journals such as Blood, Cancer Immunology Immunotherapy, The Journal of Immunology, Immunobiology and Trends in biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.